Delivery Order SPE2DB22D3016-SPE2DB24FAGH8
- Not listed
- This federal contract award, valued at $10,447.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The contract is for the supply of Afinitor 7.5 mg tablets, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has been awarded an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 by DLA to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Afinitor 5 mg tablets and has a ceiling value of $12,352.52. It is a firm fixed price delivery order contract with a performance period ending on July 29, 2025. The contract is not set aside and was awarded on July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $10,402.66, is for the delivery of AFINITOR 10 MG TABLET UD 28S, a specialty pharmaceutical product. The contract is a firm fixed price arrangement with a completion date of March 28, 2024. No set-aside designation was used...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Afinitor 10 mg tablets. The contract has a ceiling value of $20,805.32 and a period of performance ending on September 20, 2024. The contract is a firm-fixed-price type, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, valued at $678,553.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a range of pharmaceutical products and medical supplies to the U.S. government. The $25,547.09 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Afinitor 10 mg tablets, a specialty pharmaceutical product. The contract has a ceiling value of $41,610.64 and an ultimate completion date of October 21, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various government agencies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, worth $10,685.92, is for the delivery of Inlyta 5 mg tablets. The contract has no set-aside designation, indicating full and open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential...
- This federal contract award is for a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,846.25, is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $270,417.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and various medical devices and equipment, to support military treatment facilities and healthcare programs. The contract has a period of performance through May 7, 2024 and is...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAGH8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,914.38, is for the delivery of Afinitor Disperz 2 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award does not have a set-aside designation, indicating open competition. The contract supports the DLA's mission to provide medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 12/19/23 |